Texas Children’s Hospital Reaches Landmark Settlement Over Pediatric Medical Care Practices
In a significant legal development, Texas Children’s Hospital (TCH) has entered into a landmark resolution with the U.S. Department of Justice (DOJ) and the Texas Attorney General. The agreement follows a national investigation into the provision of certain medical procedures on minors, often referred to as “gender-affirming care.”
The settlement includes substantial financial penalties and a fundamental shift in how the hospital will approach specific pediatric treatments. This resolution marks the first major outcome of the Department of Justice’s ongoing investigation into violations of federal law regarding these procedures.
Financial Penalties and Allegations of Fraud
As part of the agreement, Texas Children’s Hospital has agreed to pay $10 million to resolve allegations regarding its billing practices. The Department of Justice alleges that the hospital submitted false billings to both public and private payors to secure insurance coverage for pediatric procedures.
According to the DOJ, these actions violated several federal statutes, including:
- The False Claims Act
- The Federal Food, Drug, and Cosmetic Act
- Federal fraud and conspiracy laws
“The Justice Department will use every weapon at its disposal to end the destructive and discredited practice of so-called ‘gender-affirming care’ for children,” stated Acting Attorney General Todd Blanche. He emphasized that the resolution aims to protect vulnerable children and hold medical providers accountable.
Mandated Changes to Pediatric Care Protocols
The settlement mandates immediate changes to the medical services provided to minors at Texas Children’s Hospital. Under the terms coordinated with Texas Attorney General Ken Paxton, the hospital has committed to ceasing the performance of specific “sex-rejecting procedures” on children.
These prohibited treatments include:
- The administration of puberty blockers
- The administration of cross-sex hormones
Establishment of the First-Ever Detransition Clinic
In a move aimed at addressing the needs of those previously treated, the settlement requires the establishment of a first-of-its-kind detransition clinic. This facility will be dedicated to providing medical care to children who have been harmed by the provision of the aforementioned procedures.
The hospital has also agreed to dedicate millions of dollars toward the provision of medical care for these “detransitioners,” ensuring that resources are available for those seeking to reverse or address the effects of previous treatments.
Key Takeaways
- Settlement Amount: TCH will pay $10 million to resolve false billing allegations.
- Procedure Restrictions: The hospital will no longer administer puberty blockers or cross-sex hormones to minors.
- New Medical Facility: A specialized detransition clinic will be established to care for affected children.
- Legal Basis: The settlement addresses violations of the False Claims Act and the Federal Food, Drug, and Cosmetic Act.
Frequently Asked Questions
What prompted this Department of Justice investigation?
The investigation was part of a national effort to examine violations of federal law in connection with the provision of medical procedures on minors related to gender identity.
What specific procedures are being halted at Texas Children’s Hospital?
The hospital has committed to no longer performing procedures that include the administration of puberty blockers and cross-sex hormones to children.
What is the purpose of the new detransition clinic?
The clinic is designed to provide specialized medical care to children and adolescents who have experienced harm or complications following the administration of gender-related medical procedures.
As medical protocols and legal frameworks continue to evolve, this settlement represents a pivotal moment in the intersection of pediatric medicine, federal law, and healthcare accountability in the United States.